The reasons for the delay in registration of the Russian vaccine EMA and WHO are named

Differences in European and Russian legislation lead to delays in drug approval from coronavirus “Sputnik V”, said Alexander Gunzburg, head of the Gamaleya Center. In an interview with Vechernyaya Moskva, he noted that Sputnik V brilliantly copes with protecting the body from a wide range of coronavirus strains. However, officials from the European Medicines Agency (EMA) and the World Health Organization (WHO) do not want to see the results of the vaccination campaign. The Russian drug has not yet received an EMA approval for use in the European Union.

Sputnik V is the world’s first officially registered coronavirus vaccine. The drug is now registered in 70 countries with a total population of 4 billion people. To date, WHO has recommended 7 vaccines for emergency use, and 13 more drugs, including Sputnik V and Epivaccorona, are at various stages of study.

Formerly the official representative of the Ministry of Foreign Affairs of the Russian Federation Maria Zakharova reported that the head WHO thanked Russia for the president’s call Vladimir Putin on mutual recognition of vaccines.

Source: Вести.Ru by

*The article has been translated based on the content of Вести.Ru by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!